Vaccination using epitope peptide

2 trials

Sponsors

Institute of Medical Science The University of Tokyo, Department of Urology, Kinki University School of Medicine

Conditions

advanced renal cell carcinomaunresectable colorectal cancer

Phase 1

Phase I clinical trial of epitope peptides based vaccines both targeting RNF43 and VEGFR2 in patients with advanced colorectal cancer.

Active, not recruitingJPRN-UMIN000000956

Institute of Medical Science The University of Tokyounresectable colorectal cancer

Start: 2007-12-01Target: 6Updated: 2026-06-29

Phase I clinical trial of epitope peptides based vaccines targeting VEGFR1 in patients with advanced renal cell carcinoma

Active, not recruitingJPRN-UMIN000004911

Department of Urology, Kinki University School of Medicineadvanced renal cell carcinoma

Start: 2007-07-01Target: 18Updated: 2026-06-29